Pyridam Farma Tbk PT

The company's capital structure is highly leveraged, with a debt-to-equity ratio of 6.31, indicating a significant reliance on debt financing. Its liquidity position is assessed as medium, with a current ratio of 1.24, suggesting limited short-term liquidity cushion. The company's price-to-book ratio of 3.46 implies that the market values the company at a premium to its book value, but this is not supported by positive earnings or cash flow. Free cash flow is negative at -256.15 billion IDR, and operating cash flow is also negative at -364.28 billion IDR, indicating ongoing cash burn. Profitability metrics are weak, with a return on equity of -0.495 and a return on assets of -0.0561, both significantly below industry norms. The company reported a net loss of 379.67 billion IDR and an operating loss of 217.20 billion IDR, reflecting poor operational performance. Gross profit of 583.14 billion IDR is insufficient to cover operating expenses, contributing to the net loss. Geographic and segment exposure is not explicitly detailed in the available data, but the company operates primarily in Indonesia. Revenue concentration in a single market increases exposure to local economic and regulatory risks. The absence of disclosed international operations or segment breakdowns limits visibility into diversification strategies. Growth trajectory is negative, with no clear indication of improvement in the near term. The company's operating income and net income are both in negative territory, and there is no evidence of a turnaround in the current fiscal year. The lack of positive cash flow and the high debt burden suggest that the company may face challenges in sustaining operations without external financing. Risk factors include liquidity constraints and the potential for dilution, although the latter is currently assessed as low. The company's negative net cash position after subtracting total debt is a key flag, indicating a high risk of insolvency if cash flow does not improve. The absence of a clear path to profitability or debt reduction increases the risk profile. Recent events include the publication of the latest financial results, which show continued losses and negative cash flow. No significant corporate actions or strategic initiatives have been disclosed in the available data. The company's financial health remains a concern, with no immediate signs of improvement in its operational or financial performance.